The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
Morning Overview on MSN
Xanadu lines up $287M for a data center as its SPAC deal nears
Quantum computing startup Xanadu is set to receive $287 million in government-backed funding to build a dedicated data center, a major capital infusion arriving just as the company’s $3.6 billion ...
We're handing out report cards on big moves, including the Rasheed Walker and Kyler Murray signings.
Revised 3.2. Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C COR 2a: For adults with an LDL-C level <70 mg/dL (<1.8 mmol/L), measurement of direct LDL-C or modified LDL-C estimate is reasonable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results